+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Mono Vaccine Market 2024-2028

  • PDF Icon

    Report

  • 139 Pages
  • July 2024
  • Region: Global
  • TechNavio
  • ID: 5681424
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The mono vaccine market is forecasted to grow by USD 2.47 billion during 2023-2028, accelerating at a CAGR of 4.5% during the forecast period. The report on the mono vaccine market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increase in pediatric population, initiatives from government agencies, and recent drug approvals and product innovations.

The mono vaccine market is segmented as below:

By Type

  • Meningococcal vaccine
  • Japanese encephalitis vaccine
  • Hepatitis vaccine
  • Yellow fever vaccine
  • Others

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the increase in mergers and acquisitions (M&A) as one of the prime reasons driving the mono vaccine market growth during the next few years. Also, advancement in vaccine delivery system and increasing research on combination therapies will lead to sizable demand in the market.

The report on the mono vaccine market covers the following areas:

  • Mono vaccine market sizing
  • Mono vaccine market forecast
  • Mono vaccine market industry analysis
A robust vendor analysis within the report is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading mono vaccine market vendors that include AstraZeneca PLC, Aurobindo Pharma Ltd., Bavarian Nordic AS, China National Pharmaceutical Group Corp., Dynavax Technologies Corp., GlaxoSmithKline PLC, Johnson and Johnson Services Inc., Merck and Co. Inc., Moderna Inc., Pfizer Inc., Sanofi SA, Serum Institute of India Pvt. Ltd., Shenzhen Kangtai Biological Products Co. Ltd., Valneva SE, and VBI Vaccines Inc. Also, the mono vaccine market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Type
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis
3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ million)
Data Table on Global - Market size and forecast 2023-2028 ($ million)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global Mono Vaccine Market 2018 - 2022
Historic Market Size - Data Table on Global Mono Vaccine Market 2018 - 2022 ($ million)
4.2 Type segment analysis 2018 - 2022
Historic Market Size - Type Segment 2018 - 2022 ($ million)
4.3 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.4 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Type
6.1 Market segments
Chart on Type - Market share 2023-2028 (%)
Data Table on Type - Market share 2023-2028 (%)
6.2 Comparison by Type
Chart on Comparison by Type
Data Table on Comparison by Type
6.3 Meningococcal vaccine - Market size and forecast 2023-2028
Chart on Meningococcal vaccine - Market size and forecast 2023-2028 ($ million)
Data Table on Meningococcal vaccine - Market size and forecast 2023-2028 ($ million)
Chart on Meningococcal vaccine - Year-over-year growth 2023-2028 (%)
Data Table on Meningococcal vaccine - Year-over-year growth 2023-2028 (%)
6.4 Japanese encephalitis vaccine - Market size and forecast 2023-2028
Chart on Japanese encephalitis vaccine - Market size and forecast 2023-2028 ($ million)
Data Table on Japanese encephalitis vaccine - Market size and forecast 2023-2028 ($ million)
Chart on Japanese encephalitis vaccine - Year-over-year growth 2023-2028 (%)
Data Table on Japanese encephalitis vaccine - Year-over-year growth 2023-2028 (%)
6.5 Hepatitis vaccine - Market size and forecast 2023-2028
Chart on Hepatitis vaccine - Market size and forecast 2023-2028 ($ million)
Data Table on Hepatitis vaccine - Market size and forecast 2023-2028 ($ million)
Chart on Hepatitis vaccine - Year-over-year growth 2023-2028 (%)
Data Table on Hepatitis vaccine - Year-over-year growth 2023-2028 (%)
6.6 Yellow fever vaccine - Market size and forecast 2023-2028
Chart on Yellow fever vaccine - Market size and forecast 2023-2028 ($ million)
Data Table on Yellow fever vaccine - Market size and forecast 2023-2028 ($ million)
Chart on Yellow fever vaccine - Year-over-year growth 2023-2028 (%)
Data Table on Yellow fever vaccine - Year-over-year growth 2023-2028 (%)
6.7 Others - Market size and forecast 2023-2028
Chart on Others - Market size and forecast 2023-2028 ($ million)
Data Table on Others - Market size and forecast 2023-2028 ($ million)
Chart on Others - Year-over-year growth 2023-2028 (%)
Data Table on Others - Year-over-year growth 2023-2028 (%)
6.8 Market opportunity by Type
Market opportunity by Type ($ million)
Data Table on Market opportunity by Type ($ million)
7 Customer Landscape
7.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
8 Geographic Landscape
8.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2023-2028 (%)
Data Table on Market share By Geographical Landscape 2023-2028 (%)
8.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
8.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ million)
Data Table on North America - Market size and forecast 2023-2028 ($ million)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
8.4 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ million)
Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
8.5 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ million)
Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
8.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
8.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ million)
Data Table on US - Market size and forecast 2023-2028 ($ million)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
8.8 Germany - Market size and forecast 2023-2028
Chart on Germany - Market size and forecast 2023-2028 ($ million)
Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Chart on Germany - Year-over-year growth 2023-2028 (%)
Data Table on Germany - Year-over-year growth 2023-2028 (%)
8.9 UK - Market size and forecast 2023-2028
Chart on UK - Market size and forecast 2023-2028 ($ million)
Data Table on UK - Market size and forecast 2023-2028 ($ million)
Chart on UK - Year-over-year growth 2023-2028 (%)
Data Table on UK - Year-over-year growth 2023-2028 (%)
8.10 France - Market size and forecast 2023-2028
Chart on France - Market size and forecast 2023-2028 ($ million)
Data Table on France - Market size and forecast 2023-2028 ($ million)
Chart on France - Year-over-year growth 2023-2028 (%)
Data Table on France - Year-over-year growth 2023-2028 (%)
8.11 China - Market size and forecast 2023-2028
Chart on China - Market size and forecast 2023-2028 ($ million)
Data Table on China - Market size and forecast 2023-2028 ($ million)
Chart on China - Year-over-year growth 2023-2028 (%)
Data Table on China - Year-over-year growth 2023-2028 (%)
8.12 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)
9 Drivers, Challenges, and Opportunity/Restraints
9.1 Market drivers
9.2 Market challenges
9.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
9.4 Market opportunities/restraints
10 Competitive Landscape
10.1 Overview
10.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
10.3 Landscape disruption
Overview on factors of disruption
10.4 Industry risks
Impact of key risks on business
11 Competitive Analysis
11.1 Companies profiled
Companies covered
11.2 Market positioning of companies
Matrix on companies position and classification
11.3 AstraZeneca Plc
AstraZeneca Plc - Overview
AstraZeneca Plc - Product / Service
AstraZeneca Plc - Key news
AstraZeneca Plc - Key offerings
11.4 China National Pharmaceutical Group Corp.
China National Pharmaceutical Group Corp. - Overview
China National Pharmaceutical Group Corp. - Product / Service
China National Pharmaceutical Group Corp. - Key offerings
11.5 Dynavax Technologies Corp.
Dynavax Technologies Corp. - Overview
Dynavax Technologies Corp. - Product / Service
Dynavax Technologies Corp. - Key offerings
11.6 GlaxoSmithKline Plc
GlaxoSmithKline Plc - Overview
GlaxoSmithKline Plc - Business segments
GlaxoSmithKline Plc - Key news
GlaxoSmithKline Plc - Key offerings
GlaxoSmithKline Plc - Segment focus
11.7 Merck and Co. Inc.
Merck and Co. Inc. - Overview
Merck and Co. Inc. - Business segments
Merck and Co. Inc. - Key news
Merck and Co. Inc. - Key offerings
Merck and Co. Inc. - Segment focus
11.8 Moderna Inc.
Moderna Inc. - Overview
Moderna Inc. - Product / Service
Moderna Inc. - Key offerings
11.9 Pfizer Inc.
Pfizer Inc. - Overview
Pfizer Inc. - Product / Service
Pfizer Inc. - Key news
Pfizer Inc. - Key offerings
11.10 Sanofi SA
Sanofi SA - Overview
Sanofi SA - Business segments
Sanofi SA - Key news
Sanofi SA - Key offerings
Sanofi SA - Segment focus
11.11 Serum Institute of India Pvt. Ltd.
Serum Institute of India Pvt. Ltd. - Overview
Serum Institute of India Pvt. Ltd. - Product / Service
Serum Institute of India Pvt. Ltd. - Key offerings
11.12 Shenzhen Kangtai Biological Products Co. Ltd.
Shenzhen Kangtai Biological Products Co. Ltd. - Overview
Shenzhen Kangtai Biological Products Co. Ltd. - Product / Service
Shenzhen Kangtai Biological Products Co. Ltd. - Key offerings
12 Appendix
12.1 Scope of the report
12.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
12.3 Currency conversion rates for US$
Currency conversion rates for US$
12.4 Research methodology
Research methodology
12.5 Data procurement
Information sources
12.6 Data validation
Data validation
12.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
12.8 Data synthesis
Data synthesis
12.9 360 degree market analysis
360 degree market analysis
12.10 List of abbreviations
List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Type
Exhibits 6: Executive Summary - Chart on Incremental Growth
Exhibits 7: Executive Summary - Data Table on Incremental Growth
Exhibits 8: Executive Summary - Chart on Company Market Positioning
Exhibits 9: Parent Market
Exhibits 10: Data Table on - Parent Market
Exhibits 11: Market characteristics analysis
Exhibits 12: Value Chain Analysis
Exhibits 13: Offerings of companies included in the market definition
Exhibits 14: Market segments
Exhibits 15: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 16: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 17: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 18: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 19: Historic Market Size - Data Table on Global Mono Vaccine Market 2018 - 2022 ($ million)
Exhibits 20: Historic Market Size - Type Segment 2018 - 2022 ($ million)
Exhibits 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits 23: Five forces analysis - Comparison between 2023 and 2028
Exhibits 24: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 29: Chart on Market condition - Five forces 2023 and 2028
Exhibits 30: Chart on Type - Market share 2023-2028 (%)
Exhibits 31: Data Table on Type - Market share 2023-2028 (%)
Exhibits 32: Chart on Comparison by Type
Exhibits 33: Data Table on Comparison by Type
Exhibits 34: Chart on Meningococcal vaccine - Market size and forecast 2023-2028 ($ million)
Exhibits 35: Data Table on Meningococcal vaccine - Market size and forecast 2023-2028 ($ million)
Exhibits 36: Chart on Meningococcal vaccine - Year-over-year growth 2023-2028 (%)
Exhibits 37: Data Table on Meningococcal vaccine - Year-over-year growth 2023-2028 (%)
Exhibits 38: Chart on Japanese encephalitis vaccine - Market size and forecast 2023-2028 ($ million)
Exhibits 39: Data Table on Japanese encephalitis vaccine - Market size and forecast 2023-2028 ($ million)
Exhibits 40: Chart on Japanese encephalitis vaccine - Year-over-year growth 2023-2028 (%)
Exhibits 41: Data Table on Japanese encephalitis vaccine - Year-over-year growth 2023-2028 (%)
Exhibits 42: Chart on Hepatitis vaccine - Market size and forecast 2023-2028 ($ million)
Exhibits 43: Data Table on Hepatitis vaccine - Market size and forecast 2023-2028 ($ million)
Exhibits 44: Chart on Hepatitis vaccine - Year-over-year growth 2023-2028 (%)
Exhibits 45: Data Table on Hepatitis vaccine - Year-over-year growth 2023-2028 (%)
Exhibits 46: Chart on Yellow fever vaccine - Market size and forecast 2023-2028 ($ million)
Exhibits 47: Data Table on Yellow fever vaccine - Market size and forecast 2023-2028 ($ million)
Exhibits 48: Chart on Yellow fever vaccine - Year-over-year growth 2023-2028 (%)
Exhibits 49: Data Table on Yellow fever vaccine - Year-over-year growth 2023-2028 (%)
Exhibits 50: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibits 51: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibits 52: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits 53: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits 54: Market opportunity by Type ($ million)
Exhibits 55: Data Table on Market opportunity by Type ($ million)
Exhibits 56: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 57: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 58: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 59: Chart on Geographic comparison
Exhibits 60: Data Table on Geographic comparison
Exhibits 61: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 62: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 63: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 64: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 65: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 66: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 67: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 68: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 69: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 70: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 71: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 72: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 73: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 74: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 75: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 76: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 77: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits 78: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits 79: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 80: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 81: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 82: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 83: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 84: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 85: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 86: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 87: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits 88: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits 89: Chart on France - Market size and forecast 2023-2028 ($ million)
Exhibits 90: Data Table on France - Market size and forecast 2023-2028 ($ million)
Exhibits 91: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibits 92: Data Table on France - Year-over-year growth 2023-2028 (%)
Exhibits 93: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits 94: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits 95: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits 96: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits 97: Market opportunity By Geographical Landscape ($ million)
Exhibits 98: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 99: Impact of drivers and challenges in 2023 and 2028
Exhibits 100: Overview on criticality of inputs and factors of differentiation
Exhibits 101: Overview on factors of disruption
Exhibits 102: Impact of key risks on business
Exhibits 103: Companies covered
Exhibits 104: Matrix on companies position and classification
Exhibits 105: AstraZeneca Plc - Overview
Exhibits 106: AstraZeneca Plc - Product / Service
Exhibits 107: AstraZeneca Plc - Key news
Exhibits 108: AstraZeneca Plc - Key offerings
Exhibits 109: China National Pharmaceutical Group Corp. - Overview
Exhibits 110: China National Pharmaceutical Group Corp. - Product / Service
Exhibits 111: China National Pharmaceutical Group Corp. - Key offerings
Exhibits 112: Dynavax Technologies Corp. - Overview
Exhibits 113: Dynavax Technologies Corp. - Product / Service
Exhibits 114: Dynavax Technologies Corp. - Key offerings
Exhibits 115: GlaxoSmithKline Plc - Overview
Exhibits 116: GlaxoSmithKline Plc - Business segments
Exhibits 117: GlaxoSmithKline Plc - Key news
Exhibits 118: GlaxoSmithKline Plc - Key offerings
Exhibits 119: GlaxoSmithKline Plc - Segment focus
Exhibits 120: Merck and Co. Inc. - Overview
Exhibits 121: Merck and Co. Inc. - Business segments
Exhibits 122: Merck and Co. Inc. - Key news
Exhibits 123: Merck and Co. Inc. - Key offerings
Exhibits 124: Merck and Co. Inc. - Segment focus
Exhibits 125: Moderna Inc. - Overview
Exhibits 126: Moderna Inc. - Product / Service
Exhibits 127: Moderna Inc. - Key offerings
Exhibits 128: Pfizer Inc. - Overview
Exhibits 129: Pfizer Inc. - Product / Service
Exhibits 130: Pfizer Inc. - Key news
Exhibits 131: Pfizer Inc. - Key offerings
Exhibits 132: Sanofi SA - Overview
Exhibits 133: Sanofi SA - Business segments
Exhibits 134: Sanofi SA - Key news
Exhibits 135: Sanofi SA - Key offerings
Exhibits 136: Sanofi SA - Segment focus
Exhibits 137: Serum Institute of India Pvt. Ltd. - Overview
Exhibits 138: Serum Institute of India Pvt. Ltd. - Product / Service
Exhibits 139: Serum Institute of India Pvt. Ltd. - Key offerings
Exhibits 140: Shenzhen Kangtai Biological Products Co. Ltd. - Overview
Exhibits 141: Shenzhen Kangtai Biological Products Co. Ltd. - Product / Service
Exhibits 142: Shenzhen Kangtai Biological Products Co. Ltd. - Key offerings
Exhibits 143: Inclusions checklist
Exhibits 144: Exclusions checklist
Exhibits 145: Currency conversion rates for US$
Exhibits 146: Research methodology
Exhibits 147: Information sources
Exhibits 148: Data validation
Exhibits 149: Validation techniques employed for market sizing
Exhibits 150: Data synthesis
Exhibits 151: 360 degree market analysis
Exhibits 152: List of abbreviations

Executive Summary

The following companies are recognized as the key players in the global mono vaccine market: AstraZeneca PLC, Aurobindo Pharma Ltd., Bavarian Nordic AS, China National Pharmaceutical Group Corp., Dynavax Technologies Corp., GlaxoSmithKline PLC, Johnson and Johnson Services Inc., Merck and Co. Inc., Moderna Inc., Pfizer Inc., Sanofi SA, Serum Institute of India Pvt. Ltd., Shenzhen Kangtai Biological Products Co. Ltd., Valneva SE, and VBI Vaccines Inc..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is increase in mergers and acquisitions (M&A)."

According to the report, one of the major drivers for this market is the increase in pediatric population.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AstraZeneca Plc
  • Aurobindo Pharma Ltd.
  • Bavarian Nordic AS
  • China National Pharmaceutical Group Corp.
  • Dynavax Technologies Corp.
  • GlaxoSmithKline Plc
  • Johnson and Johnson Services Inc.
  • Merck and Co. Inc.
  • Moderna Inc.
  • Pfizer Inc.
  • Sanofi SA
  • Serum Institute of India Pvt. Ltd.
  • Shenzhen Kangtai Biological Products Co. Ltd.
  • Valneva SE
  • VBI Vaccines Inc.